Free Trial

Pyxis Oncology (PYXS) SEC Filings & 10K Form

$3.23
-0.07 (-2.12%)
(As of 10/17/2024 ET)

Recent Pyxis Oncology SEC Filings

DateFilerForm TypeView
09/25/2024
3:08 PM
Pyxis Oncology (Filer)
Form DEF 14A
09/13/2024
3:26 PM
Pyxis Oncology (Filer)
Form PRE 14A
08/14/2024
3:25 PM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/12/2024
3:17 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
4:31 PM
Metzger Michael A (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:26 PM
Metzger Michael A (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/10/2024
6:56 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
6:55 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
7:00 AM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:16 PM
Pyxis Oncology (Filer)
Form ARS
04/26/2024
3:15 PM
Pyxis Oncology (Filer)
Form DEF 14A
04/26/2024
3:16 PM
Pyxis Oncology (Filer)
Form DEFA14A
04/03/2024
11:15 PM
Pyxis Oncology (Filer)
Form EFFECT
03/28/2024
3:31 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:32 PM
Civik Thomas (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:32 PM
HUMPHREY RACHEL (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Cline Darren S (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:49 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
6:44 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:54 PM
Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:45 PM
Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2024
3:31 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:02 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:28 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pyxis Oncology (Subject)
Form SC 13G/A
12/29/2023
3:33 PM
Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:50 PM
Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/28/2023
6:22 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:44 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:46 PM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2023
3:34 PM
Pyxis Oncology (Filer)
Form 8-K/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PYXS) was last updated on 10/18/2024 by MarketBeat.com Staff
From Our Partners